Frontline Combo

Quick links to important sections

Frontline Combo

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Frontline Combo

Property Description
Active Ingredients Fipronil, (S)-Methoprene
Form Spot-on solution (Clear amber)
Pharmacological Class Ectoparasiticide (Insecticide/Acaricide + Insect Growth Regulator)
Route of Administration Topical application
Origin Synthetic organic chemical mixture

Frontline Combo: Identity and Pharmaceutical Form

Frontline Combo is a specialized, synthetic veterinary medicinal product designated as an ectoparasiticide intended for topical application. It is formulated as a clear amber spot-on solution, which is applied directly to the skin of the animal. This product is structurally identified as a combination product, uniting two chemical entities with distinct mechanisms, which is clinically recognized for providing sustained parasite control across various geographical regions. This specific dosage form facilitates the non-systemic delivery of the active compounds, primarily ensuring their spread across the host’s skin and coat.

Composition: Fipronil and (S)-Methoprene Combination

The efficacy of Frontline Combo is based on its dual composition, featuring the active ingredients: Fipronil and (S)-Methoprene. Fipronil is an acaricide and insecticide belonging to the phenylpyrazole chemical family. Complementing this, (S)-Methoprene is functionally classified as an Insect Growth Regulator (IGR), specifically a Juvenile Hormone Analogue. The two agents, along with stabilizing excipients, are contained within an alcoholic solution base, designed for optimal topical delivery.

General Therapeutic Purpose and Dual Action Benefit

The general therapeutic purpose of this combined formulation is the management of existing external parasite infestations and the prevention of their subsequent multiplication. This strategy utilizes Fipronil for the rapid adulticidal effect on pests currently on the host, while the (S)-Methoprene component delivers crucial ovicidal and larvicidal activity. Fipronil combined with Methoprene is effective for achieving robust control of the flea life cycle. This integrated approach is designed to offer more persistent control compared to treatments that focus solely on the removal of adult parasites.

What side effects are possible with Frontline Combo?

Official Safety Profile and Adverse Reactions

The medicine's safety profile is documented by regulatory authorities, classifying most reported adverse reactions as Very Rare, meaning they occur in less than 1 out of 10,000 animals treated. These reported effects are typically associated with the site of topical application or transient systemic signs.

Regulatory Classification of Adverse Effects

System-Organ Class (SOC) Examples of Officially Documented Reactions
Skin and Subcutaneous Tissue Transient hair loss (alopecia), local itching (pruritus), redness (erythema).
Gastrointestinal Vomiting, excessive salivation (hypersalivation).
Nervous System Transient neurological signs, such as depression or increased sensitivity.

Time-Related Patterns and Safety Limitations

Certain effects are noted as being time-dependent. Hypersalivation, if observed, occurs transiently and is typically linked to the animal licking the application site immediately after treatment. Localized skin reactions are also described as transient and are expected to resolve without intervention.

Official labeling includes specific restrictions and safety limitations. The product is strictly contraindicated for use in rabbits due to the risk of severe adverse reactions, including mortality. Furthermore, it should not be used in animals exhibiting known hypersensitivity to either Fipronil or (S)-Methoprene, or in animals that are less than 8 weeks old due to a lack of adequate safety data. Use is also not recommended in animals that are currently sick or in a convalescent state.

Overdose and Emergency Response

The official regulatory profile for Frontline Combo overdose is primarily structured around the documented escalation of known adverse event risks upon exposure to doses higher than recommended. The most probable outcome of an overdose is an increased likelihood of experiencing documented clinical manifestations.

These presentations are generally described as reversible. Documented nervous system signs include temporary depression and increased sensitivity to stimulation. Gastrointestinal effects such as vomiting and brief hypersalivation may occur, particularly if the animal licks the application site. Local skin reactions at the application spot may involve transient discoloration, itching, and a temporary sticky appearance of the hair. Rare respiratory signs have also been reported.

Management of an overdose relies entirely on addressing the documented symptoms, as the official labeling confirms that no specific antidote is known for the active ingredients. The regulatory mandate focuses on preventative action: animals should always be treated with the correct product size and volume based strictly on bodyweight. Regulators explicitly caution against over-dosing and strictly prohibit using the dog formulation in cats or ferrets due to the inherent risk of overdose. The labeling does not contain explicit phrasing requiring immediate medical attention.

Therapeutic Uses of Frontline Combo

What Frontline Combo Treats: Main Uses and Benefits


The product is used in situations involving certain distressing symptoms linked to common external parasites. This solution is applicable within clinical settings that involve acute or disruptive symptom patterns caused by these parasites.

Therapeutic Focus and Symptom Clusters

It is used for managing symptoms associated with infestations of fleas, ticks, and biting lice. The product is considered relevant in conditions characterized by periods of heightened symptoms, specifically used when groups of symptoms appear suddenly or fluctuate, such as those related to Flea Allergy Dermatitis (FAD). It is applied across domains where additional symptomatic support is needed.

Quick Fact: Relevant for Symptoms that interfere with daily functioning.

In these clinical scenarios, the product may assist with symptoms that interfere with daily comfort. It provides support that helps ease the overall symptom burden, contributing to easing the overall symptom load and supporting general well-being during symptomatic phases.

Eligibility and Restrictions for Use

Official Eligibility Profile: Who Can and Cannot Use Frontline Combo?

Regulatory documents define specific population eligibility based on species, age, weight, and health status. The product is contraindicated in certain populations and not recommended for others where safety data is absent.


Absolute Contraindications and Prohibited Populations

Category Contraindication Status
Non-Target Species Rabbits must not use the product due to severe adverse reactions.
Species Cross-Use The dog-specific variant is contraindicated for use in cats and ferrets due to the risk of overdosing.
Hypersensitivity Animals with known hypersensitivity to Fipronil, (S)-Methoprene, or any excipient are contraindicated.
Health Status Sick or convalescent animals must not use the product.

Age- and Status-Related Restrictions

Use is not recommended for: Puppies less than 8 weeks old; Kittens less than 8 weeks old and/or weighing less than 1 kg; and Ferrets less than 6 months old. Regarding Reproductive Status, the product can be used in pregnant and lactating dogs and cats. However, safety is not established for pregnant and lactating ferrets; conditional use requires a veterinarian's risk-benefit assessment.

What should I know about interactions with other medicines?

Interactions with other medicines and products


The official regulatory profile for Frontline Combo is characterized by a specific status regarding co-administration with other medicinal products and a single constraint related to the product’s excipient base.

Interaction Scope and Status

Interaction Scope Official Regulatory Documentation Status
Medicinal product interactions None known.
Mechanistic basis (PK/PD) Not documented.
Timing-based rules None documented for co-administered medicines.
Interaction-related restrictions Restriction for individuals with known hypersensitivity to alcohol.

The regulatory documentation explicitly states that no interactions with other veterinary medicinal products and other forms of interaction are known according to the product's official prescribing information. This structure means the official label does not document any necessary timing separations, prohibited combinations, or specific pharmacokinetic or pharmacodynamic effects with co-administered drugs.

Interaction-Context Constraint

No co-administration is classified as contraindicated based on an interaction risk. The only constraint documented by regulators concerns the product's formulation:

  • The solution is prepared in an alcoholic solution. Individuals with a known hypersensitivity to alcohol must avoid contact with the solution, as noted in the official regulatory documentation.

Mechanism of Action

Targeting the Parasite's Central Nervous System

This mechanism is defined by the action of Fipronil, which functions as an antagonist (blocker) on GABA-gated chloride channels in the nervous system of adult parasites. This molecular interaction prevents the crucial influx of chloride ions, which normally regulates nerve signals. The resulting failure to inhibit nerve cells leads to nerve and muscle hyperexcitation and subsequent loss of motor function, culminating in the elimination of the adult parasite.


Interrupting the Parasite's Growth Cycle

This second mechanism involves (S)-Methoprene, a structural mimic of the natural juvenile hormone. The continuous presence of this mimic disrupts the biological signaling necessary for normal molting and metamorphosis. This results in the developmental arrest of immature stages (eggs and larvae), which hinders the emergence of new adult parasites from the surrounding environment. The overall effect is achieved by simultaneously attacking the active adult population and neutralizing the next generation.

Dosage and Administration Information

Frontline Combo is a specialized ectoparasiticide that is administered solely through topical application directly to the animal's skin. The dosing regimen is based on a unit-dose approach, where the entire contents of a pre-filled, single-use pipette must be applied. Selection of the correct pipette size depends strictly on the animal’s species and its accurately determined body weight, utilizing specific dose bands for dogs (Small, Medium, Large, Extra Large) and a single size for cats and ferrets.

The administration is applied to the skin at a non-accessible area, specifically the base of the neck in front of the shoulder blades. To ensure delivery, the coat must be parted until the skin is clearly visible before the contents are emptied onto that site.

In terms of frequency, the product is used intermittently, and a minimum interval of four weeks must be observed between any two successive applications. This minimum treatment interval governs the earliest date for re-application.

Specific population rules apply to ensure correct use. The product is not for use in puppies or kittens that are under eight weeks of age. Additionally, kittens must weigh at least 1 kg to receive the cat formulation. A mandatory special procedural condition requires that the animal must not be bathed or immersed in water for 48 hours following application. This set of instructions dictates the standardized procedure for correct administration.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Frontline Combo

This section describes the types of scientific research that have been conducted on the Fipronil and (S)-Methoprene spot-on solution, detailing what researchers explored and where data remain insufficient, without providing any clinical advice.


Evidence for Use in Treating Flea and Tick Infestations

Research examined this solution for use in treating existing infestations of adult fleas and ticks. The research included multiple study types, such as short-term randomized controlled trials (RCTs) and multicentric field trials, to examine animals presenting with external parasites. These studies monitored outcomes related to physical discomfort by monitoring measurements of existing adult flea and tick counts at specific, short intervals, such as within the first 48 hours following application.

Research also explored the patterns of parasite count evolution following re-infestation challenges over a defined time interval, often up to four weeks. The research highlights measurements of the rate at which parasite counts decreased during the study period.

What remains uncertain are the patterns of parasite count evolution beyond the typical one-month assessment period, especially for tick control, where follow-up durations were limited. Study results reflect the specific conditions under which they were conducted and research does not determine whether an individual will respond similarly.

Evidence for Prevention of Flea Multiplication

Research also explores the component that was studied for its activity against specific flea life stages. Evidence is derived from controlled laboratory RCTs specifically designed to assess the (S)-Methoprene component. Studies monitored measurements related to the parasitic life cycle by measuring the percentage of flea eggs that were monitored for viability and the rate at which immature stages were prevented from developing into adult fleas.

Findings describe patterns observed in the studies where measurements of development failure were maintained for a period of up to eight weeks. The exact degree of measured developmental failure in naturally contaminated outdoor or indoor environments is less characterized.

Key Studies & References

  1. Fipronil-(S)-Methoprene Ceva spot-on solution for cats 1-5 kg - Summary of Product Characteristics (SPC) / Regulatory Efficacy Claims.

Frequently Asked Questions (FAQ)

Common questions about Frontline Combo (FAQ)


Q: What is the main difference between Frontline Combo and Frontline Plus?

The product is officially recognized as a combination product because it contains two distinct active ingredients: Fipronil and (S)-Methoprene. Fipronil targets adult parasites, and (S)-Methoprene works to interrupt the life cycle of the new generation. This specific dual composition is what defines its official classification.

Q: Why does Frontline Combo also include the word 'Combo' in its name?

The term 'Combo' in the product name refers to the fact that the solution is a combination of two active substances, Fipronil and (S)-Methoprene. This formulation is designed to provide comprehensive control by attacking both the adult parasite population and preventing the development of new, immature life stages.

Q: What specific type of parasites is Frontline Combo designed to treat?

According to official product information, this solution is indicated for the treatment of infestations with fleas and ticks. Additionally, regulatory documents state the product is indicated for the elimination of biting lice.

Q: How long does it take for Frontline Combo to start killing fleas after application?

Official product efficacy data indicates that the solution achieves insecticidal action against new flea infestations within 24 hours of exposure. Ticks are typically killed within 48 hours after contact with the treated animal.

Q: How long does the protection from one dose of Frontline Combo typically last?

Studies indicate that the insecticidal efficacy against new adult flea infestations lasts for 4 weeks. The component that interrupts the life cycle maintains prevention of flea multiplication for up to six weeks following application.

Q: What should I do if I get the Frontline Combo solution on my own skin?

The product can cause skin and eye irritation in humans. Official guidelines state that if the solution comes into contact with the fingers, washing your hands with soap and water is recommended. In the event of accidental contact with the eyes, rinsing them carefully with pure water is indicated.

Q: Why is it important to apply the solution directly to the skin and not just the fur?

Application directly to the skin is necessary to ensure the active ingredients are fully available, a concept known as bioavailability. Applying the solution only to the hair or coat may result in reduced efficacy because the ingredients cannot properly spread across the skin surface to the oil glands.

Q: What if my pet has a medical condition, can they still use Frontline Combo?

Regulatory documents advise that the product should not be used on animals that are currently sick (for example, having systemic diseases or fever). It is also recommended that the product is not used on animals that are in a convalescent state (recovering from illness).

Q: Does Frontline Combo treat chewing lice in addition to fleas and ticks?

Yes, according to official indications for use, the product is effective for the elimination of biting lice (or chewing lice) in addition to fleas and ticks.

Q: Can I use a pet shampoo that contains another insecticide along with Frontline Combo?

Official regulatory documents state that no interactions with other veterinary medicinal products are known. However, the guidance does not specifically address non-veterinary products, such as shampoos that contain insecticides. For concurrent use with non-veterinary products, consultation with a veterinary professional is often appropriate.

Q: Is there a concern about using Frontline Combo on frail or older animals?

The official prescribing information advises against using the product on animals that are sick or convalescent. There is no specific caution related to only an animal's age, but consultation with a veterinary professional may be appropriate before applying to frail or geriatric animals.

Q: How quickly should I expect to see an improvement in a heavy flea infestation after applying the product?

The solution begins its flea-killing action within 24 hours of application. In the case of an existing infestation, any fleas seen on the animal are generally newly acquired parasites that will be killed soon after contact, leading to a reduction in the overall parasite load over time.

Q: If I still see live fleas on my pet after using Frontline Combo, does that mean the product is not working?

No topical product prevents fleas from initially jumping onto a pet. If live fleas are observed, they are typically newly acquired parasites that will be killed after contact with the treated animal, generally within 24 hours.

Q: How does Frontline Combo help address flea dermatitis or skin irritation caused by fleas?

Regulatory documents confirm that the veterinary medicinal product can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD), a common skin irritation caused by fleas.

Q: Is Frontline Combo considered a repellent that keeps fleas and ticks from jumping onto the animal?

The product is classified as an ectoparasiticide, meaning it is designed to kill parasites on the host. It is not a repellent and does not prevent fleas or ticks from initially jumping onto the animal. The efficacy relies on killing the parasites after they come into contact with the treated skin and hair.

Q: How is the medicine distributed across the animal's body after topical application?

Once applied, the solution is distributed and stored within the sebaceous glands (the oil glands) of the skin. It then spreads over the entire body surface using the animal’s natural oils. The sebaceous glands act as a reservoir to continuously replenish the product onto the skin and hair coat.

Q: Does Frontline Combo absorb into the bloodstream, or does it stay on the skin surface?

The product is designed to localize and work on the surface of the skin and hair, stored within the sebaceous glands. According to regulatory information, the product is effective without needing to enter the bloodstream of the animal.

Q: How long after application must I wait before handling my pet or allowing children to play with it?

Official guidance states that treated animals should not be handled until the application site is dry. Similarly, children should not be allowed to play with the treated animal until the application area has completely dried to prevent accidental contact.

Q: Is it normal for a pet's fur to look oily or greasy after applying the product?

Application site reactions, including transient hair discoloration or scaling, have been noted as very rare adverse events in official reports. While not explicitly stating 'greasy,' the change in hair appearance is acknowledged in the product's safety profile.

Q: Why are some people concerned that fleas have become resistant to products like Frontline Combo?

Regulatory documentation notes that using the product in a way that deviates from the instructions, such as underdosing, may increase the resistance selection pressure among parasites. This deviation can lead to reduced efficacy of the solution.

Q: Are there any specific breed sensitivities reported for Frontline Combo?

Official guidance includes a warning for long-hair breeds, advising that special attention should be paid to ensure the solution is applied directly to the skin, not the hair. This is to prevent lower bioavailability, which can reduce the product's effectiveness.

Q: Is Frontline Combo still effective if it was applied slightly incorrectly?

Regulatory documents indicate that applying the product incorrectly, such as not getting the solution directly onto the skin, could result in lower bioavailability. This means the ingredients cannot spread properly, which may lead to reduced efficacy.

Q: What common application mistakes should I try to avoid?

Official warnings caution against applying the product to an area where the animal can easily lick it off. Furthermore, it is important to take steps to avoid animals licking each other following treatment, as this can lead to adverse effects.

How should Frontline Combo be stored and disposed of?

The required storage and disposal conditions for Frontline Combo are defined by regulatory labeling to maintain product stability and ensure proper environmental handling.

Official Storage Conditions

  • Temperature and Environment: The product must be stored below 30°C and should be kept in a dry place, protected from direct sunlight.
  • Packaging and Stability: It must be stored in its original packaging (blister pack). The shelf life of the product as packaged for sale is 3 years.
  • Child Safety: The solution must be kept out of the sight and reach of children.

Official Disposal Instructions

Disposal of unused or expired product must be carried out in accordance with local requirements. Due to environmental restrictions, the product and its container must not contaminate surface waters.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Frontline Combo found in:

A-Z Index: